 <h1>Doxepin topical Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2>In Summary</h2><p><b>Commonly reported side effects of doxepin topical include:</b> application site reaction and drowsiness.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to doxepin topical: topical cream</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, doxepin topical may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>Check with your doctor as soon as possible if any of the following side effects occur while taking doxepin topical:</p><p>
<i>More common</i>
</p><ul>
<li>Burning, crawling, or tingling sensation of the skin</li>
<li>swelling at the site of application</li>
<li> worsening of eczema and itching</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Fever</li>
</ul><p>
<i>Symptoms of overdose</i>
</p><ul>
<li>Abdominal pain and swelling</li>
<li>blurring of vision</li>
<li>convulsions (seizures)</li>
<li> decreased awareness or responsiveness</li>
<li>difficulty in breathing</li>
<li>difficulty in passing urine</li>
<li>dizziness, fainting, or lightheadedness</li>
<li> drowsiness</li>
<li>enlarged pupils</li>
<li> excessive dryness of mouth</li>
<li>extremely high fever or body temperature</li>
<li>extremely low body temperature </li>
<li>fast heartbeat</li>
<li>increased or excessive unconscious or jerking movements</li>
<li>incurable constipation</li>
<li>irregular heartbeat</li>
<li> unconsciousness</li>
<li>vomiting</li>
<li> weak pulse</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of doxepin topical may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Burning and/or stinging at the site of application</li>
<li>changes in taste</li>
<li>dizziness</li>
<li>drowsiness</li>
<li>dryness and tightness of skin</li>
<li>dryness of mouth and/or lips</li>
<li>emotional changes</li>
<li>headache</li>
<li>thirst</li>
<li>unusual tiredness or weakness </li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Anxiety</li>
<li>irritation, tingling, scaling, and cracking of skin</li>
<li>nausea</li>
</ul><p>
<!-- end topical cream --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to doxepin topical: topical cream</i></p><h3>Local</h3><p><b>Very common</b> (10% or more): Burning/stinging (23%)</p>
<p><b>Common</b> (1% to 10%): Other application site reaction</p>
<p><b>Frequency not reported</b>: Irritation, tingling<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Drowsiness (up to 22%)</p>
<p><b>Common</b> (1% to 10%): Dizziness, taste perversion</p>
<p><b>Uncommon</b> (0.1% to 1%): Headache</p>
<p><b>Frequency not reported</b>: Lightheadedness, taste bitter, taste metallic<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Dry mouth</p>
<p><b>Uncommon</b> (0.1% to 1%): Numbness of tongue, nausea</p>
<p><b>Frequency not reported</b>: Dry lips, dry throat, thirst, indigestion, vomiting, diarrhea, constipation<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Pruritus, eczema exacerbated</p>
<p><b>Frequency not reported</b>: Localized rash, pruritus exacerbated</p>
<p><b>Postmarketing reports</b>: Allergic contact dermatitis<sup>[Ref]</sup></p><h3>General</h3><p>The most frequently reported adverse effects were drowsiness and burning/stinging at application site.<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Frequency not reported</b>: Urinary retention<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Type IV hypersensitivity reaction<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Blurred vision, dry eyes<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Fatigue/tiredness, edema</p>
<p><b>Uncommon</b> (0.1% to 1%): Fever</p>
<p><b>Frequency not reported</b>: Vertigo<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Mental emotional changes</p>
<p><b>Uncommon</b> (0.1% to 1%): Nervousness/anxiety<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Zonalon (doxepin topical)." Bioglan Pharmaceutical Inc, Malvern, PA. </p><p id="ref_2">2. MHRA. Medicines and Health Regulatory Agency "MHRA Drug Safety Update. Available from: URL: http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate."  </p></div>
<div class="more-resources" id="moreResources">
<h2>More about doxepin topical</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>4 Reviews</li>
<li>Drug class: topical antihistamines</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Doxepin Topical &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Prudoxin, Zonalon</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Atopic Dermatitis</li>
<li>Dermatitis</li>
<li>Eczema</li>
<li>Lichen Simplex Chronicus</li>
<li>Pruritus</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to doxepin topical: topical cream</i></p><h3>Local</h3><p><b>Very common</b> (10% or more): Burning/stinging (23%)</p><p><b>Common</b> (1% to 10%): Other application site reaction</p><p><b>Frequency not reported</b>: Irritation, tingling<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Drowsiness (up to 22%)</p><p><b>Common</b> (1% to 10%): Dizziness, taste perversion</p><p><b>Uncommon</b> (0.1% to 1%): Headache</p><p><b>Frequency not reported</b>: Lightheadedness, taste bitter, taste metallic<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Dry mouth</p><p><b>Uncommon</b> (0.1% to 1%): Numbness of tongue, nausea</p><p><b>Frequency not reported</b>: Dry lips, dry throat, thirst, indigestion, vomiting, diarrhea, constipation<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Pruritus, eczema exacerbated</p><p><b>Frequency not reported</b>: Localized rash, pruritus exacerbated</p><p><b>Postmarketing reports</b>: Allergic contact dermatitis<sup>[Ref]</sup></p><h3>General</h3><p>The most frequently reported adverse effects were drowsiness and burning/stinging at application site.<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Frequency not reported</b>: Urinary retention<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Type IV hypersensitivity reaction<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Blurred vision, dry eyes<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Fatigue/tiredness, edema</p><p><b>Uncommon</b> (0.1% to 1%): Fever</p><p><b>Frequency not reported</b>: Vertigo<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Mental emotional changes</p><p><b>Uncommon</b> (0.1% to 1%): Nervousness/anxiety<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Zonalon (doxepin topical)." Bioglan Pharmaceutical Inc, Malvern, PA. </p><p id="ref_2">2. MHRA. Medicines and Health Regulatory Agency "MHRA Drug Safety Update. Available from: URL: http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate."  </p><h2>More about doxepin topical</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>4 Reviews</li>
<li>Drug class: topical antihistamines</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Doxepin Topical &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Atopic Dermatitis</li>
<li>Dermatitis</li>
<li>Eczema</li>
<li>Lichen Simplex Chronicus</li>
<li>Pruritus</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>